United States Federal Circuit
Eli Lilly and Co. v. Teva Pharm. USA., Inc., 09-1071
In a patent infringement action related to a drug for the treatment and prevention of postmenopausal osteoporosis, the district court's order in favor of plaintiff is affirmed where the court did not abuse its discretion in extending a statutory thirty-month stay preventing the FDA from approving defendant's new drug application due to defendant's discovery violations.
Appellate Information
- Decided 02/24/2009
- Published 02/24/2009
Judges
Court
- United States Federal Circuit